Skip to main content
SpringerLink
Log in

Motilität

  • Conference paper
Handbuch Gastroenterologie 2010

Part of the book series: Handbuch Update-Seminar ((UPDATESEMINAR))

  • 1076 Accesses

Zusamenfassung

Die deutschen Leitlinien zur Durchführung und Interpretation der Ösophagus-Manometrie fassen die gemeinsamen Empfehlungen der Deutschen Gesellschaften für Neurogastroenterologie und Motilität (DGNM), Verdauungs- und Stoffwechselkrankheiten (DGVS) und Allgemeine und Viszerale Chirurgie (DGAV) übersichtlich und und auch praktisch brauchbar zusammen.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

9.7 Literatur

  1. Keller J, van der Voort I, Pehl C, et al. (Performance and interpretation of esophageal manometry: recommendations of the German societies for neurogastroenterology and motility (DGNM), for digestive and metabolic diseases (DGVS) and for general and visceral surgery (DGAV)). Zeitschrift fur Gastroenterologie 2009;47:830–45.

    Article  CAS  PubMed  Google Scholar 

  2. Makharia GK, Seith A, Sharma SK, et al. Structural and functional abnormalities in lungs in patients with achalasia. Neurogastroenterol Motil 2009;21:603–8, e20.

    Article  CAS  PubMed  Google Scholar 

  3. Campos GM, Vittinghoff E, Rabl C, et al. Endoscopic and surgical treatments for achalasia: a systematic review and meta-analysis. Ann Surg 2009;249:45–57.

    Article  PubMed  Google Scholar 

  4. Kilic A, Schuchert MJ, Pennathur A, et al. Long-term outcomes of laparoscopic Heller myotomy for achalasia. Surgery 2009;146:826–31; discussion 31-3.

    Article  PubMed  Google Scholar 

  5. Hocke M, Schone U, Richert H, et al. Every slow-wave impulse is associated with motor activity of the human stomach. American journal of physiology 2009;296:G709–16.

    Article  CAS  PubMed  Google Scholar 

  6. Brennan IM, Feltrin KL, Nair NS, et al. Effects of the phases of the menstrual cycle on gastric emptying, glycemia, plasma GLP-1 and insulin, and energy intake in healthy lean women. American journal of physiology 2009;297:G602–10.

    CAS  PubMed  Google Scholar 

  7. Keller J, Andresen V, Wolter J, et al. Influence of clinical parameters on the results of 13C-octanoic acid breath tests: examination of different mathematical models in a large patient cohort. Neurogastroenterol Motil 2009;21:1039–e83.

    Article  CAS  PubMed  Google Scholar 

  8. Odunsi ST, Camilleri M, Szarka LA, et al. Optimizing analysis of stable isotope breath tests to estimate gastric emptying of solids. Neurogastroenterol Motil 2009;21:706–e38.

    Article  CAS  PubMed  Google Scholar 

  9. Jung HK, Choung RS, Locke GR, 3rd, et al. The incidence, prevalence, and outcomes of patients with gastroparesis in Olmsted County, Minnesota, from 1996 to 2006. Gastroenterology 2009;136:1225–33.

    Article  PubMed  Google Scholar 

  10. Keller J, Beglinger C, Holst JJ, et al. Mechanisms of Gastric Emptying Disturbances in Chronic and Acute Inflammation of the Distal Gastrointestinal Tract. American journal of physiology 2009.

    Google Scholar 

  11. Arts J, Caenepeel P, Bisschops R, et al. Efficacy of the long-acting repeatable formulation of the somatostatin analogue octreotide in postoperative dumping. Clin Gastroenterol Hepatol 2009;7:432–7.

    Article  CAS  PubMed  Google Scholar 

  12. Amiot A, Tchikviladze M, Joly F, et al. Frequency of mitochondrial defects in patients with chronic intestinal pseudo-obstruction. Gastroenterology 2009;137:101–9.

    Article  CAS  PubMed  Google Scholar 

  13. Amiot A, Joly F, Alves A, et al. Long-term outcome of chronic intestinal pseudo-obstruction adult patients requiring home parenteral nutrition. The American journal of gastroenterology 2009;104:1262–70.

    Article  PubMed  Google Scholar 

  14. Lindberg G, Iwarzon M, Tornblom H. Clinical features and long-term survival in chronic intestinal pseudo-obstruction and enteric dysmotility. Scand J Gastroenterol 2009;44:692–9.

    Article  PubMed  Google Scholar 

  15. Lindberg G, Tornblom H, Iwarzon M, et al. Full-thickness biopsy findings in chronic intestinal pseudo-obstruction and enteric dysmotility. Gut 2009;58:1084–90.

    Article  CAS  PubMed  Google Scholar 

  16. Khoshini R, Dai SC, Lezcano S, et al. A systematic review of diagnostic tests for small intestinal bacterial overgrowth. Digestive diseases and sciences 2008;53:1443–54.

    Article  PubMed  Google Scholar 

  17. Ford AC, Spiegel BM, Talley NJ, et al. Small Intestinal Bacterial Overgrowth in Irritable Bowel Syndrome: Systematic Review and Meta-Analysis. Clin Gastroenterol Hepatol 2009.

    Google Scholar 

  18. Peralta S, Cottone C, Doveri T, et al. Small intestine bacterial overgrowth and irritable bowel syndrome-related symptoms: experience with Rifaximin. World J Gastroenterol 2009;15:2628–31.

    Article  CAS  PubMed  Google Scholar 

  19. Pimentel M. Review of rifaximin as treatment for SIBO and IBS. Expert opinion on investigational drugs 2009;18:349–58.

    Article  CAS  PubMed  Google Scholar 

  20. Spiegel BM, Chey WD, Chang L. Bacterial overgrowth and irritable bowel syndrome: unifying hypothesis or a spurious consequence of proton pump inhibitors? The American journal of gastroenterology 2008;103:2972–6.

    Article  PubMed  Google Scholar 

  21. Haag S, Senf W, Tagay S, et al. Is there any association between disturbed gastrointestinal visceromotor and sensory function and impaired quality of life in functional dyspepsia? Neurogastroenterol Motil 2009.

    Google Scholar 

  22. Ford AC, Marwaha A, Lim A, et al. Systematic Review and Meta-Analysis of the Prevalence of Irritable Bowel Syndrome in Individuals With Dyspepsia. Clin Gastroenterol Hepatol 2009.

    Google Scholar 

  23. Ford AC, Ching E, Moayyedi P. Meta-analysis: yield of diagnostic tests for coeliac disease in dyspepsia. Alimentary pharmacology & therapeutics 2009;30:28–36.

    Article  CAS  Google Scholar 

  24. Giangreco E, D’Agate C, Barbera C, et al. Prevalence of celiac disease in adult patients with refractory functional dyspepsia: value of routine duodenal biopsy. World J Gastroenterol 2008;14:6948–53.

    Article  PubMed  Google Scholar 

  25. van Marrewijk CJ, Mujakovic S, Fransen GA, et al. Effect and cost-effectiveness of step-up versus step-down treatment with antacids, H2-receptor antagonists, and proton pump inhibitors in patients with new onset dyspepsia (DIAMOND study): a primary-care-based randomised controlled trial. Lancet 2009;373:215–25.

    Article  PubMed  Google Scholar 

  26. Braden B, Caspary W, Borner N, et al. Clinical effects of STW 5 (Iberogast) are not based on acceleration of gastric emptying in patients with functional dyspepsia and gastroparesis. Neurogastroenterol Motil 2009;21:632–8, e25.

    Article  CAS  PubMed  Google Scholar 

  27. Ran ZH, Yuan YZ, Li ZS, et al. The efficacy of Combizym in the treatment of Chinese patients with dyspepsia: a multicenter, randomized, placebo-controlled and cross-over study: Shanghai Combizym Clinical Cooperative Group. Journal of digestive diseases 2009;10:41–8.

    Article  CAS  PubMed  Google Scholar 

  28. Enck P, Vinson B, Malfertheiner P, et al. The placebo response in functional dyspepsiareanalysis of trial data. Neurogastroenterol Motil 2009;21:370–7.

    Article  CAS  PubMed  Google Scholar 

  29. Bond B, Quinlan J, Dukes GE, et al. Irritable bowel syndrome: more than abdominal pain and bowel habit abnormalities. Clin Gastroenterol Hepatol 2009;7:73–9.

    Article  PubMed  Google Scholar 

  30. Ringel Y, Williams RE, Kalilani L, et al. Prevalence, characteristics, and impact of bloating symptoms in patients with irritable bowel syndrome. Clin Gastroenterol Hepatol 2009;7:68–72; quiz 3.

    Article  PubMed  Google Scholar 

  31. Accarino A, Perez F, Azpiroz F, et al. Abdominal distention results from caudo-ventral redistribution of contents. Gastroenterology 2009;136:1544–51.

    Article  PubMed  Google Scholar 

  32. Villoria A, Azpiroz F, Soldevilla A, et al. Abdominal accommodation: a coordinated adaptation of the abdominal wall to its content. The American journal of gastroenterology 2008;103:2807–15.

    Article  PubMed  Google Scholar 

  33. Simren M. Bloating and abdominal distention: not so poorly understood anymorel Gastroenterology 2009;136:1487–90.

    Article  PubMed  Google Scholar 

  34. Hanevik K, Dizdar V, Langeland N, et al. Development of functional gastrointestinal disorders after Giardia lamblia infection. BMC gastroenterology 2009;9:27.

    Article  PubMed  Google Scholar 

  35. Jung IS, Kim HS, Park H, et al. The clinical course of postinfectious irritable bowel syndrome: a five-year follow-up study. J Clin Gastroenterol 2009;43:534–40.

    Article  PubMed  Google Scholar 

  36. Jellema P, van der Windt DA, Schellevis FG, et al. Systematic review: accuracy of symptom-based criteria for diagnosis of irritable bowel syndrome in primary care. Alimentary pharmacology & therapeutics 2009;30:695–706.

    Article  CAS  Google Scholar 

  37. Lembo AJ, Neri B, Tolley J, et al. Use of serum biomarkers in a diagnostic test for irritable bowel syndrome. Alimentary pharmacology & therapeutics 2009;29:834–42.

    Article  CAS  Google Scholar 

  38. Walker MM, Talley NJ, Prabhakar M, et al. Duodenal mastocytosis, eosinophilia and intraepithelial lymphocytosis as possible disease markers in the irritable bowel syndrome and functional dyspepsia. Alimentary pharmacology & therapeutics 2009;29:765–73.

    Article  CAS  Google Scholar 

  39. Ford AC, Chey WD, Talley NJ, et al. Yield of diagnostic tests for celiac disease in individuals with symptoms suggestive of irritable bowel syndrome: systematic review and meta-analysis. Archives of internal medicine 2009;169:651–8.

    Article  PubMed  Google Scholar 

  40. Verdu EF, Armstrong D, Murray JA. Between celiac disease and irritable bowel syndrome: the “no man’s land” of gluten sensitivity. The American journal of gastroenterology 2009;104:1587–94.

    Article  PubMed  Google Scholar 

  41. Wedlake L, A’Hern R, Russell D, et al. Systematic review: the prevalence of idiopathic bile acid malabsorption as diagnosed by SeHCAT scanning in patients with diarrhoea-predominant irritable bowel syndrome. Alimentary pharmacology & therapeutics 2009;30:707–17.

    Article  CAS  Google Scholar 

  42. Camilleri M, Nadeau A, Tremaine WJ, et al. Measurement of serum 7alpha-hydroxy-4-cholesten-3-one (or 7alphaC4), a surrogate test for bile acid malabsorption in health, ileal disease and irritable bowel syndrome using liquid chromatography-tandem mass spectrometry. Neurogastroenterol Motil 2009;21:734–e43.

    Article  CAS  PubMed  Google Scholar 

  43. Herve S, Beaugerie L, Bouhnik Y, et al. Irritable bowel syndrome is more frequent in patients hospitalized for ischaemic colitis: results of a case-control study. Neurogastroenterol Motil 2009;21:1170–e102.

    Article  CAS  PubMed  Google Scholar 

  44. Hamilton W, Peters TJ, Bankhead C, et al. Risk of ovarian cancer in women with symptoms in primary care: population based case-control study. BMJ (Clinical research ed 2009;339:b2998.

    Article  Google Scholar 

  45. Pilotto A, Franceschi M, Vitale D, et al. The prevalence of diarrhea and its association with drug use in elderly outpatients: a multicenter study. The American journal of gastroenterology 2008;103:2816–23.

    Article  PubMed  Google Scholar 

  46. Damman CJ, Surawicz CM. The gut microbiota: a microbial arsenal protecting us from infectious and radiation-induced diarrhea. Gastroenterology 2009;136:722–4.

    Article  PubMed  Google Scholar 

  47. Preidis GA, Versalovic J. Targeting the human microbiome with antibiotics, probiotics, and prebiotics: gastroenterology enters the metagenomics era. Gastroenterology 2009;136:2015–31.

    Article  CAS  PubMed  Google Scholar 

  48. Kerckhoffs AP, Samsom M, van der Rest ME, et al. Lower Bifidobacteria counts in both duodenal mucosa-associated and fecal microbiota in irritable bowel syndrome patients. World J Gastroenterol 2009;15:2887–92.

    Article  PubMed  Google Scholar 

  49. Piche T, Barbara G, Aubert P, et al. Impaired intestinal barrier integrity in the colon of patients with irritable bowel syndrome: involvement of soluble mediators. Gut 2009;58:196–201.

    Article  CAS  PubMed  Google Scholar 

  50. Quigley E. Gut permeability in irritable bowel syndrome: more leaks add to slightly inflamed bowel syndrome conspiracy theory. Gastroenterology 2009;137:728–30.

    Article  PubMed  Google Scholar 

  51. Ohman L, Isaksson S, Lindmark AC, et al. T-cell activation in patients with irritable bowel syndrome. The American journal of gastroenterology 2009;104:1205–12.

    Article  PubMed  Google Scholar 

  52. Langhorst J, Junge A, Rueffer A, et al. Elevated human beta-defensin-2 levels indicate an activation of the innate immune system in patients with irritable bowel syndrome. The American journal of gastroenterology 2009;104:404–10.

    Article  CAS  PubMed  Google Scholar 

  53. Cremon C, Gargano L, Morselli-Labate AM, et al. Mucosal immune activation in irritable bowel syndrome: gender-dependence and association with digestive symptoms. The American journal of gastroenterology 2009;104:392–400.

    Article  CAS  PubMed  Google Scholar 

  54. Buhner S, Li Q, Vignali S, et al. Activation of human enteric neurons by supernatants of colonic biopsy specimens from patients with irritable bowel syndrome. Gastroenterology 2009;137:1425–34.

    Article  CAS  PubMed  Google Scholar 

  55. Austin GL, Dalton CB, Hu Y, et al. A very low-carbohydrate diet improves symptoms and quality of life in diarrhea-predominant irritable bowel syndrome. Clin Gastroenterol Hepatol 2009;7:706–8 e1.

    Article  CAS  PubMed  Google Scholar 

  56. Bijkerk CJ, de Wit NJ, Muris JW, et al. Soluble or insoluble fibre in irritable bowel syndrome in primary care?. Randomised placebo controlled trial. BMJ (Clinical research ed 2009;339:b3154.

    Article  CAS  Google Scholar 

  57. Merat S, Khalili S, Mostajabi P, et al. The Effect of Enteric-Coated, Delayed-Release Peppermint Oil on Irritable Bowel Syndrome. Digestive diseases and sciences 2009.

    Google Scholar 

  58. Ladabaum U, Sharabidze A, Levin TR, et al. Citalopram Is Not Effective Therapy for Nondepressed Patients With Irritable Bowel Syndrome. Clin Gastroenterol Hepatol 2009.

    Google Scholar 

  59. Targownik LE, Bolton JM, Metge CJ, et al. Selective serotonin reuptake inhibitors are associated with a modest increase in the risk of upper gastrointestinal bleeding. The American journal of gastroenterology 2009;104:1475–82.

    Article  CAS  PubMed  Google Scholar 

  60. Saito YA, Rey E, Almazar-Elder AE, et al. A Randomized, Double-Blind, Placebo-Controlled Trial of St John’s Wort for Treating Irritable Bowel Syndrome. The American journal of gastroenterology 2009.

    Google Scholar 

  61. Ford AC, Talley NJ, Schoenfeld PS, et al. Efficacy of antidepressants and psychological therapies in irritable bowel syndrome: systematic review and meta-analysis. Gut 2009;58:367–78.

    Article  CAS  PubMed  Google Scholar 

  62. Abdul-Baki H, El H, II, Elzahabi L, et al. A randomized controlled trial of imipramine in patients with irritable bowel syndrome. World J Gastroenterol 2009;15:3636–42.

    Article  CAS  PubMed  Google Scholar 

  63. Zijdenbos IL, de Wit NJ, van der Heijden GJ, et al. Psychological treatments for the management of irritable bowel syndrome. Cochrane database of systematic reviews (Online) 2009:CD006442.

    Google Scholar 

  64. Tack J, van Outryve M, Beyens G, et al. Prucalopride (Resolor) in the treatment of severe chronic constipation in patients dissatisfied with laxatives. Gut 2009;58:357–65.

    Article  CAS  PubMed  Google Scholar 

  65. Ford AC, Brandt LJ, Young C, et al. Efficacy of 5-HT3 antagonists and 5-HT4 agonists in irritable bowel syndrome: systematic review and meta-analysis. The American journal of gastroenterology 2009;104:1831–43; quiz 44.

    Article  CAS  PubMed  Google Scholar 

  66. Simren M, Ohman L, Olsson J, et al. Clinical trial: the effect of a fermented milk containing three probiotic bacteria in patients with irritable bowel syndrome (IBS) — a randomized, double-blind, controlled study. Alimentary pharmacology & therapeutics 2009.

    Google Scholar 

  67. Silk DB, Davis A, Vulevic J, et al. Clinical trial: the effects of a trans-galactooligosaccharide prebiotic on faecal microbiota and symptoms in irritable bowel syndrome. Alimentary pharmacology & therapeutics 2009;29:508–18.

    Article  CAS  Google Scholar 

  68. Enck P, Zimmermann K, Menke G, et al. Randomized controlled treatment trial of irritable bowel syndrome with a probiotic E.-coli preparation (DSM17252) compared to placebo. Zeitschrift fur Gastroenterologie 2009;47:209–14.

    Article  CAS  PubMed  Google Scholar 

  69. Moayyedi P, Ford AC, Talley NJ, et al. The efficacy of probiotics in the therapy of irritable bowel syndrome: a systematic review. Gut 2008.

    Google Scholar 

  70. Brenner DM, Moeller MJ, Chey WD, et al. The utility of probiotics in the treatment of irritable bowel syndrome: a systematic review. The American journal of gastroenterology 2009;104:1033–49; quiz 50.

    Article  CAS  PubMed  Google Scholar 

  71. Lembo AJ, Conboy L, Kelley JM, et al. A treatment trial of acupuncture in IBS patients. The American journal of gastroenterology 2009;104:1489–97.

    Article  PubMed  Google Scholar 

  72. Brandt LJ, Chey WD, Foxx-Orenstein AE, et al. An evidence-based position statement on the management of irritable bowel syndrome. The American journal of gastroenterology 2009;104 Suppl 1:S1–35.

    Article  PubMed  Google Scholar 

  73. Ford AC, Guyatt GH, Talley NJ, et al. Errors in the Conduct of Systematic Reviews of Pharmacological Interventions for Irritable Bowel Syndrome. The American journal of gastroenterology 2009.

    Google Scholar 

  74. Camilleri M, Papathanasopoulos A, Odunsi ST. Actions and therapeutic pathways of ghrelin for gastrointestinal disorders. Nature reviews 2009;6:343–52.

    CAS  PubMed  Google Scholar 

  75. Lee KJ, Cha DY, Cheon SJ, et al. Plasma ghrelin levels and their relationship with gastric emptying in patients with dysmotility-like functional dyspepsia. Digestion 2009;80:58–63.

    Article  CAS  PubMed  Google Scholar 

  76. Shindo T, Futagami S, Hiratsuka T, et al. Comparison of gastric emptying and plasma ghrelin levels in patients with functional dyspepsia and non-erosive reflux disease. Digestion 2009;79:65–72.

    Article  CAS  PubMed  Google Scholar 

  77. Corinaldesi R, Stanghellini V, Cremon C, et al. Effect of mesalazine on mucosal immune biomarkers in irritable bowel syndrome: a randomized controlled proof-of-concept study. Alimentary pharmacology & therapeutics 2009;30:245–52.

    Article  CAS  Google Scholar 

  78. Johnston JM, Kurtz CB, Drossman DA, et al. Pilot study on the effect of linaclotide in patients with chronic constipation. The American journal of gastroenterology 2009;104:125–32.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Medizinische Klinik, Israelitisches Krankenhaus, Orchideenstieg 14, 22297, Hamburg, Deutschland

    Prof. Dr. Peter Layer

Authors
  1. Prof. Dr. Peter Layer
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Kiinik für Aiigemein- und Viszeraichirurgie, Dr. Horst Schmidt Kiiniken GmbH, Ludwig-Erhard-Straße 100, 65199, Wiesbaden

    Christian Eli

  2. Medizinische Klinik, Israelitisches Krankenhaus, Orchideenstieg 14, 22297, Hamburg

    Peter Layer

  3. II. Medizinische Kiinik, Kiinikum Aschaffenburg, Am Hasenkopf 1, 63739, Aschaffenburg

    Wolfgang Fischbach

  4. Chirurgisches Zentrum Viszeral-, Gefäß- und Endokrine Chirurgie, HELlOS Kiinikum Wuppertal, Heusnerstraße 40, 42283, Wuppertai

    Hubert Zirngibl

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer Medizin Verlag Heidelberg

About this paper

Cite this paper

Layer, P. (2010). Motilität. In: Eli, C., Layer, P., Fischbach, W., Zirngibl, H. (eds) Handbuch Gastroenterologie 2010. Handbuch Update-Seminar. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-11635-3_9

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-11635-3_9

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-11634-6

  • Online ISBN: 978-3-642-11635-3

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation